1982
DOI: 10.1097/00003086-198203000-00019
|View full text |Cite
|
Sign up to set email alerts
|

Bilateral Total Hip Arthroplasty in a Jehovah??s Witness With Chronic Anemia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
5
0

Year Published

1989
1989
2013
2013

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(6 citation statements)
references
References 0 publications
1
5
0
Order By: Relevance
“…Although the current authors also observed similar outcomes to those reported in the literature following aseptic revisions in healthy, optimized patients, the risks of surgery must be carefully considered. 9,10,12,39 The current authors believe that their comprehensive blood optimization and management program contributed to their excellent outcomes.…”
Section: Discussionmentioning
confidence: 86%
See 1 more Smart Citation
“…Although the current authors also observed similar outcomes to those reported in the literature following aseptic revisions in healthy, optimized patients, the risks of surgery must be carefully considered. 9,10,12,39 The current authors believe that their comprehensive blood optimization and management program contributed to their excellent outcomes.…”
Section: Discussionmentioning
confidence: 86%
“…In the approximately 7 decades since the adoption of this doctrine, published case reports regarding surgical outcomes and blood management strategies in the medical literature have spanned nearly every intervening decade. [5][6][7][8][9][10][11][12][13] However, few reports have been published regarding revision THA in this subset of patients, and even fewer have systematically and objectively measured postoperative clinical outcomes. Because of the risks associated with perioperative blood loss resulting in postoperative anemia, physicians must be able to counsel their patients on expected outcomes using evidence-based data.…”
Section: Revision Total Hip Arthroplasty In Jehovah's Witnessesmentioning
confidence: 99%
“…35,36 In addition, the published reports about these patients in orthopaedic joint arthroplasty are mainly limited to the perioperative period with minimal to no follow-up evaluations. 15,16,18,[29][30][31] In this study, we assessed revision total knee arthroplasties in these patients who underwent our established blood management and found 100% implant survivorship over a mean follow-up of 62 months with excellent clinical and radiographic outcomes.…”
Section: Discussionmentioning
confidence: 99%
“…[26][27][28] A large number of orthopaedic procedures such as joint arthroplasties are performed on this patient population, however, clinical outcomes of such operations have only been reported in a limited number of studies which are mainly limited to the peri-operative period with minimal to no follow-up evaluations. 15,16,18,[29][30][31] To the best of our knowledge, after a thorough search of the English-language literature, there has been no study evaluating clinical outcomes of revision total knee arthroplasty (TKA) in Jehovah's Witness patients. Due to this lack of such reported data, we undertook this study to assess the clinical outcomes in these patients who underwent a special blood management strategy.…”
mentioning
confidence: 99%
“…Methods that have been described in the literature include pre-treatment with erythropoietin (18), preoperative haemodilution with intraoperative blood salvage (16), surgical techniques such as gentle soft tissue handling and meticulous haemostasis (7), bipolar sealers (19, 20), intravascular occlusion (21), haemostatic agents (22), and early removal of drains (8, 23). However, the preponderance of the literature investigating clinical outcomes of THA in Jehovah's Witnesses was published over two decades ago, and the few studies that enrolled large numbers of patients focused on the perioperative period rather than long-term follow-up (9, 18, 21, 24252627–28). To the best of our knowledge, there is no study of this patient population that has investigated implant survivorship, mid-term clinical outcomes, and mortality following primary THA in the setting of a comprehensive blood management strategy.…”
Section: Introductionmentioning
confidence: 99%